RxDoctor Payments Data

Namita Tuli, MD

Family Practice · Wharton, TXNPI 1689623597

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Smith+Nephew at 40.9% of the total. 2025 is the largest year on record at $1,516, 3.0 times the $507 reported in 2019. Among family practice clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,871in general payments, 2019–2025

Across 157 payments — averaging $31.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$2K
  • Reapplix Inc.$623
  • Kerecis Limited$407
  • Tactile Systems Technology Inc$297
  • Imbed Biosciences Inc.$234
  • Reddress USA, Inc.$226
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$4,871100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,871 in reported general payments places this provider in the 95th percentile of 646 family practice providers in Texas.

See all family practice providers in Texas

Medicare billing

Part B allowed, 2024
$178,047
Medicare patients
171
Services billed
2,241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav76$722
Doxycycline Monohydrate26$563
Levofloxacin93$405
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim88$336
Doxycycline Hyclate12$178
Clindamycin Hcl12$159
Fluconazole18$152

Paid to pharmacies, not to this prescriber.

Other family practice in Wharton

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →